Canal-U

Mon compte

Résultats de recherche

Nombre de programmes trouvés : 14
Conférences

le (14m26s)

Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 - Workshop 5 : Will we be able to answer the question of HDL as a therapeutic target after the CETP inhibitor trials? (Eric STROES)

... disease and to identify and select new drug biotargets.➢ One major question relates to the value of biomarker-guided and/or risk guided therapy and how to design appropriate trials to test these therapeutic strategies. Should therapy be targeted to...
Voir la vidéo

 
FMSH
 
Facebook Twitter
Mon Compte